Wanbangde Pharmaceutical Holding Group Co Ltd: A Snapshot

Wanbangde Pharmaceutical Holding Group Co Ltd, a prominent player in the health care sector, is headquartered in Wenling, China. The company is renowned for its extensive range of pharmaceutical products, including antibiotic drugs, respiratory drugs, cardiovascular drugs, vitamin tablets, and various health care drugs. In addition to pharmaceuticals, Wanbangde also offers medical devices, broadening its footprint in the health care industry.

Stock Market Presence

Wanbangde is listed on the Shenzhen Stock Exchange, where it has been a public entity since its Initial Public Offering (IPO) on November 20th, 2006. As of May 27, 2025, the company’s close price stood at 5.6 CNH. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of 7.78 CNH on December 15, 2024, and a 52-week low of 3.9 CNH on September 17, 2024. The company’s market capitalization is currently valued at 3.5 billion CNH.

Financial Metrics

The company’s financial health can be partially gauged by its price-to-earnings (P/E) ratio, which is currently 83.97. This metric provides investors with insight into the company’s earnings relative to its share price, although it should be considered alongside other financial indicators for a comprehensive analysis.

Industry and Operations

Despite being categorized under the Health Care sector, Wanbangde’s industry classification is Metals & Mining. This classification may reflect the company’s involvement in the production of certain raw materials or components used in its pharmaceutical and medical device offerings.

For more detailed information about Wanbangde Pharmaceutical Holding Group Co Ltd’s products and services, interested parties can visit their official website at www.chinawepon.com .

In summary, Wanbangde Pharmaceutical Holding Group Co Ltd continues to be a significant entity in the health care sector, with a diverse product portfolio and a notable presence on the Shenzhen Stock Exchange.